Clinical Trials for Respiratory Syncytial Virus Infections

Find clinical trials for respiratory syncytial virus infections. Discover research opportunities and treatment options in your area.

15 Active Trials Found

Showing 15 trials on this page

Page 1 of 1

An Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 Study

NCT ID: NCT06534892

This clinical trial is exploring how well a vaccine for Respiratory Syncytial Virus (RSV) works in older adults aged 60 and above. The study aims to find out the best time to give a booster shot af...

Recruiting

Phase: PHASE3 Type: interventional Locations: Fort Worth, Texas, United States, Saint Louis, Missouri, United States +251 more

Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children

NCT ID: NCT05026749

The clinical trial titled "Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children" is studying whether the antibiotic azithromycin can help children who are ...

Recruiting

Phase: PHASE3 Type: interventional Locations: Omaha, Nebraska, United States, Cleveland, Ohio, United States +8 more

RSV Vaccine in Transplant Recipients

NCT ID: NCT06593210

This clinical trial is studying a new RSV vaccine designed specifically for adult patients who have received lung transplants or stem cell transplants. The goal is to see how safe the vaccine is an...

Recruiting

Phase: PHASE3 Type: interventional Locations: Toronto, , Canada

A Sudy to Evaluate the Efficacy and Safety of TNM001 in High-risk Infants

NCT ID: NCT06710925

This clinical trial is studying a new treatment called TNM001 for high-risk infants who may get sick from Respiratory Syncytial Virus (RSV). RSV is a common virus that can cause serious breathing p...

Not yet recruiting

Phase: PHASE3 Type: interventional Locations: Chengdu, Sichuan, China, Chongqing, Sichuan, China

A Study to Describe the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine IN006 in Healthy Adults

NCT ID: NCT06287450

This clinical trial is studying a new vaccine called IN006, which is designed to protect against respiratory syncytial virus (RSV) infections. The main goals of the study are to see how safe the va...

Not yet recruiting

Phase: PHASE1 Type: interventional

A Study to Describe the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine IN006 in Healthy Adult Aged 18 Years and Above

NCT ID: NCT06645665

This clinical trial is studying a new vaccine called IN006, designed to protect against Respiratory Syncytial Virus (RSV) infections in healthy adults aged 18 and older. The main goals are to see h...

Recruiting

Phase: PHASE1 Type: interventional Locations: Shanghai, Shanghai, China, Kunming, Yunnan, China

A Study in India on the Immune Response and Safety of a Respiratory Syncytial Virus (RSV) Older Adults (OA) Vaccine When Given to Older Adults 60 Years of Age and Above and Adults 50-59 Years of Age at Increased Risk (AIR) of Respiratory Syncytial Virus Lower Respiratory Tract Disease (RSV-LRTD)

NCT ID: NCT06614725

This clinical trial is studying a new vaccine designed to help protect older adults from Respiratory Syncytial Virus (RSV), a virus that can cause serious lung infections. The trial is looking spec...

Recruiting

Phase: PHASE3 Type: interventional Locations: Bangalore, , India, Kochi, , India +15 more

A Study of BLB-201 RSV Vaccine in Infants and Children

NCT ID: NCT05655182

This clinical trial is studying a new vaccine called BLB-201, which aims to protect infants and young children from a virus called respiratory syncytial virus (RSV). RSV can cause serious respirato...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States, Cincinnati, Ohio, United States +12 more

A Study to Evaluate the Safety, Immunogenicity, and Pharmacokinetics of GR2102 in Healthy Adult

NCT ID: NCT06313697

This clinical trial is studying a new injection called GR2102, aimed at preventing Respiratory Syncytial Virus (RSV) infections, which can cause serious respiratory issues, especially in young chil...

Recruiting

Phase: PHASE1 Type: interventional Locations: Jinan, Shandong, China

A Study on the Immune Response, Safety and the Occurrence of Respiratory Syncytial Virus (RSV)-Associated Respiratory Tract Illness After Administration of RSV OA Vaccine in Adults 60 Years and Older

NCT ID: NCT06551181

This clinical trial is studying a new vaccine called RSVPreF3 OA, which aims to help older adults (60 years and older) build immunity against Respiratory Syncytial Virus (RSV). The trial specifical...

Recruiting

Phase: PHASE3 Type: interventional Locations: Barcelona, , Spain, Madrid, , Spain +32 more

Human Interferon α1b Inhalation Solution Against Respiratory Syncytial Virus in Children With Lower Respiratory Tract Infections

NCT ID: NCT06363370

This clinical trial is studying a new treatment called interferon α1b, which is being tested as an inhalation solution for young children with respiratory syncytial virus (RSV) infections. RSV is a...

Recruiting

Phase: PHASE3 Type: interventional Locations: Beijing, Beijing, China

A Study to Describe the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine STR-V003 in Healthy Adults

NCT ID: NCT06344975

This clinical trial is investigating a new vaccine called STR-V003 designed to protect against respiratory syncytial virus (RSV), which can cause serious lung infections. The study aims to evaluate...

Not yet recruiting

Phase: PHASE1 Type: interventional

Identification and Clinical Validation of Biomarkers Associated With Clinical Severity in Adults Infected With RSV

NCT ID: NCT06197152

This clinical trial is focused on understanding how severe Respiratory Syncytial Virus (RSV) infections are in adults and identifying specific markers, called biomarkers, that can help predict the ...

Recruiting

Type: observational Locations: Créteil, , France

A Trial to Evaluate the Efficacy and Safety of TNM001 for the Prevention of Lower Respiratory Tract Infection Caused by Respiratory Syncytial Virus in Infants

NCT ID: NCT06083623

This clinical trial is studying a new treatment called TNM001 to see how well it can prevent lower respiratory infections caused by the Respiratory Syncytial Virus (RSV) in infants. RSV is a common...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Changsha, Hunan, China, Wuhan, Hubei, China +38 more

Epidemiology and Household Transmission of Streptococcus Pneumoniae and Respiratory Syncytial Virus

NCT ID: NCT05017519

This clinical trial is studying how two viruses, Respiratory Syncytial Virus (RSV) and Streptococcus pneumoniae, spread within households, particularly focusing on young children and older adults. ...

Not yet recruiting

Type: observational

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions